Last reviewed · How we verify
RP903
At a glance
| Generic name | RP903 |
|---|---|
| Sponsor | Risen (Suzhou) Pharma Tech Co., Ltd. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Efficacy and Indications of RP903 (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- RP903 CI brief — competitive landscape report
- RP903 updates RSS · CI watch RSS
- Risen (Suzhou) Pharma Tech Co., Ltd. portfolio CI